Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hoechst Marion Roussel ending collaborations with Alteon and Scios.

Executive Summary

HOECHST ENDING COLLABORATIONS WITH ALTEON AND SCIOS as part of Hoechst Marion Roussel's continuing efforts to pare the network of external research collaborations created by the merger of Hoechst and Marion Merrell Dow. After ending its agreements with Alteon for diabetes and Scios for Alzheimer's, HMR will have eliminated a total of three agreements brought to the company by Marion. HMR announced plans to end its collaboration with ImmuLogic in March ("The Pink Sheet" March 18, p. 15).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028347

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel